SCHEMBL368916

SCHEMBL368916

COC(=O)C(CCOc1ccc(C(CC(=O)c2ccc(=O)n(C)c2)c2ccc(Cl)cc2C)cc1)Oc1ccc(C(CC(=O)c2ccc(=O)n(C)c2)c2ccc(Cl)cc2C)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
FFAR1 O14842 10/20 0.36
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
PLA2G4A P47712 2/20 0.32
LDHA P00338 1/20 0.32
LDHB P07195 1/20 0.32
METTL3 Q86U44 1/20 0.32
METTL14 Q9HCE5 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368731 0.86 L3MBTL1 (0.35) PPARGPPARAL3MBTL1KEAP1NFE2L2
SCHEMBL368917 0.85 MAPT (0.39) L3MBTL1FFAR1GAAPLA2G4A
SCHEMBL368768 0.84 FFAR1 (0.40) L3MBTL1FFAR1PLA2G4A
SCHEMBL1390419 0.82 LMNA (0.43) L3MBTL1FFAR1KEAP1NFE2L2LMNA
SCHEMBL369581 0.80 POLB (0.40) L3MBTL1FFAR1KEAP1NFE2L2MGAM
SCHEMBL371309 0.79 POLB (0.40) L3MBTL1FFAR1KEAP1NFE2L2MGAM
SCHEMBL15832896 0.79 POLB (0.39) L3MBTL1FFAR1KEAP1NFE2L2MGAM
SCHEMBL369750 0.79 POLB (0.40) L3MBTL1FFAR1KEAP1NFE2L2MGAM
SCHEMBL368816 0.79 KMT2A (0.46) L3MBTL1FFAR1KEAP1NFE2L2MGAM
SCHEMBL368801 0.78 P2RX3 (0.42) L3MBTL1FFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 PPARG 161/4885PPARA 235/4885L3MBTL1 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.